July NCCN Academy to Focus on The Affordable Care Act, Pricing, and Quality in Oncology Care
On July 10-11, 2013, NCCN will host the NCCN Academy for Excellence & Leadership in Oncology School of Pharmaceutical & Biotech Business at the National Press Club in Washington, DC.
The 2-day event, to be moderated by Clifford Goodman, PhD, of the Lewin Group, and Robert W. Carlson, MD, Chief Executive Officer of NCCN, is an educational forum for pharmaceutical and biotech professionals to participate in and observe interactions with key stakeholders. Participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology, while gathering valuable insights into developing effective strategies for navigating the various constituencies in cancer care.
NCCN Academy, in its fifth year, provides its audience with a receptive environment in which to hear directly from thought leaders about what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually successful working relationships. Further, participants listen to expert constituents discuss how the decisions and programs are shaped by certain types of information and data, as well as their perspectives on the oncology space, its future, and its current challenges.
The interactive program will address several topics, including the anticipated October 2013 rollout of new health insurance marketplaces through the Affordable Care Act and its impact on the oncology community; issues surrounding effective pricing of new oncology drugs and devices; and defining quality oncology care. The July NCCN Academy will also feature “Meet the Experts” modules, which will provide expert insights into the consideration and decision-making processes that result in the recommendations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) and perspectives from regulatory and reimbursement experts on current trends and challenges in oncology.
NCCN Holds Its First Annual International Day
NCCN recently held its first Annual International Day in conjunction with the NCCN 18th Annual Conference: Advancing the Standard of Cancer Care. More than 20 physicians from across Latin America and 3 physicians from Turkey came to Hollywood, Florida to meet with NCCN Guidelines Panel members and NCCN staff to discuss the consideration of regional adaptations necessary for effective use of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) in their respective countries. The discussions specifically focused on application of the NCCN Guidelines for Colorectal Cancer in oncology care in Latin American and potential modifications to NCCN Guidelines for Melanoma for use in Turkey.
“We at NCCN value very highly our collaborative efforts with our international colleagues to improve the quality of care of patients with cancer,” said Robert W. Carlson, MD, CEO, NCCN. “We are gratified that the NCCN Guidelines are highly relevant on a global basis, and we look forward to further expanding our international programs.”
Nearly half of all registered users of the NCCN Guidelines on NCCN.org report that they live outside the United States. NCCN regularly works with thought leaders throughout the world to review the NCCN Guidelines, with consideration of metabolic differences in populations, local accessibility, and regulatory status of health care technologies used in cancer care in the specified country. The resulting foreign editions, regional adaptations, and consensus statements of the NCCN Guidelines are considered NCCN Guidelines derivatives. The modified NCCN Guidelines are then translated into the local language with specified modifications, published on NCCN.org, and distributed locally to aid clinicians in determining appropriate and effective cancer care.